Cytokine-scavenging Nanodecoys Reconstruct Osteoclast/osteoblast Balance Toward the Treatment of Postmenopausal Osteoporosis

Overview

Journal Sci Adv

Specialties Biology
Science

Date 2021 Nov 24

PMID 34818042

Citations 22

Authors

Yang Zhou

Yekun Deng

Zhongmin Liu

Mengyuan Yin

Mengying Hou

Ziyin Zhao

Xiaozhong Zhou

Lichen Yin

Affiliations

Soon will be listed here.

Abstract

Imbalance between osteoblasts and osteoclasts accounts for the incidence and deterioration of postmenopausal osteoporosis. Abnormally elevated RANKL and TNF-α levels after menopause promote osteoclast formation and inhibit osteoblast differentiation, respectively. Here, nanodecoys capable of scavenging RANKL and TNF-α were developed from preosteoclast (RAW 264.7 cell) membrane–coated poly(lactic--glycolic acid) (PLGA) nanoparticles, which inhibited osteoporosis and maintained bone integrity. The nanodecoys effectively escaped from macrophage capture and enabled prolonged blood circulation after systemic administration. The abundant RANK and TNF-α receptor (TNF-αR) on the cell membranes effectively neutralized RANKL and TNF-α to prevent osteoclastogenesis and promote osteoblastogenesis, respectively, thus reversing the progression of osteoporosis in the ovariectomized (OVX) mouse model. These biomimetic nanodecoys provide an effective strategy for reconstructing the osteoclast/osteoblast balance and hold great potentials for the clinical management of postmenopausal osteoporosis.

Citing Articles

Role of YAP/TAZ in bone diseases: A transductor from mechanics to biology.

Chen X, Ji X, Lao Z, Pan B, Qian Y, Yang W J Orthop Translat. 2025; 51:13-23.

PMID: 39902099 PMC: 11787699. DOI: 10.1016/j.jot.2024.12.003.

Non-diabetic elderly populations: SIRI as a risk factor and PIV as a protective factor against bone abnormalities.

Yan M, Gong P, Li X, Huang H, Wei H Front Endocrinol (Lausanne). 2024; 15:1467683.

PMID: 39610846 PMC: 11602317. DOI: 10.3389/fendo.2024.1467683.

Unleashing the Potential of Electroactive Hybrid Biomaterials and Self-Powered Systems for Bone Therapeutics.

Liu S, Manshaii F, Chen J, Wang X, Wang S, Yin J Nanomicro Lett. 2024; 17(1):44.

PMID: 39417933 PMC: 11486894. DOI: 10.1007/s40820-024-01536-9.

Enhanced vascularization and osseointegration under osteoporotic conditions through functional peptide coating on implant surfaces.

Liu J, Zhao B, Shen X, Lu D, He W, Zan X Mater Today Bio. 2024; 27:101150.

PMID: 39104902 PMC: 11298615. DOI: 10.1016/j.mtbio.2024.101150.

Macrophage membrane-reversibly camouflaged nanotherapeutics accelerate fracture healing by fostering MSCs recruitment and osteogenic differentiation.

Wu C, Yan J, Ge C, Xie L, He Y, Zhao Z J Nanobiotechnology. 2024; 22(1):411.

PMID: 38997706 PMC: 11241938. DOI: 10.1186/s12951-024-02679-y.

References

Ping Z, Wang Z, Shi J, Wang L, Guo X, Zhou W . Inhibitory effects of melatonin on titanium particle-induced inflammatory bone resorption and osteoclastogenesis via suppression of NF-κB signaling. Acta Biomater. 2017; 62:362-371. DOI: 10.1016/j.actbio.2017.08.046. View

Hofbauer L, Schoppet M . Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. JAMA. 2004; 292(4):490-5. DOI: 10.1001/jama.292.4.490. View

Nishikawa K, Iwamoto Y, Kobayashi Y, Katsuoka F, Kawaguchi S, Tsujita T . DNA methyltransferase 3a regulates osteoclast differentiation by coupling to an S-adenosylmethionine-producing metabolic pathway. Nat Med. 2015; 21(3):281-7. DOI: 10.1038/nm.3774. View

Liu J, Chen C, Liu Z, Luo Z, Rao S, Jin L . Extracellular Vesicles from Child Gut Microbiota Enter into Bone to Preserve Bone Mass and Strength. Adv Sci (Weinh). 2021; 8(9):2004831. PMC: 8097336. DOI: 10.1002/advs.202004831. View

Wu M, Chen W, Lu Y, Zhu G, Hao L, Li Y . Gα13 negatively controls osteoclastogenesis through inhibition of the Akt-GSK3β-NFATc1 signalling pathway. Nat Commun. 2017; 8:13700. PMC: 5253683. DOI: 10.1038/ncomms13700. View

Krum S, Chang J, Miranda-Carboni G, Wang C . Novel functions for NFκB: inhibition of bone formation. Nat Rev Rheumatol. 2010; 6(10):607-11. PMC: 3078572. DOI: 10.1038/nrrheum.2010.133. View

Gilbert L, He X, Farmer P, Rubin J, Drissi H, van Wijnen A . Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha. J Biol Chem. 2001; 277(4):2695-701. DOI: 10.1074/jbc.M106339200. View

Hu C, Fang R, Copp J, Luk B, Zhang L . A biomimetic nanosponge that absorbs pore-forming toxins. Nat Nanotechnol. 2013; 8(5):336-40. PMC: 3648601. DOI: 10.1038/nnano.2013.54. View

Lu X, Gilbert L, He X, Rubin J, Nanes M . Transcriptional regulation of the osterix (Osx, Sp7) promoter by tumor necrosis factor identifies disparate effects of mitogen-activated protein kinase and NF kappa B pathways. J Biol Chem. 2006; 281(10):6297-306. DOI: 10.1074/jbc.M507804200. View

10.

Schett G, David J . The multiple faces of autoimmune-mediated bone loss. Nat Rev Endocrinol. 2010; 6(12):698-706. DOI: 10.1038/nrendo.2010.190. View

11.

Xu Z, Greenblatt M, Yan G, Feng H, Sun J, Lotinun S . SMURF2 regulates bone homeostasis by disrupting SMAD3 interaction with vitamin D receptor in osteoblasts. Nat Commun. 2017; 8:14570. PMC: 5321737. DOI: 10.1038/ncomms14570. View

12.

Saito H, Gasser A, Bolamperti S, Maeda M, Matthies L, Jahn K . TG-interacting factor 1 (Tgif1)-deficiency attenuates bone remodeling and blunts the anabolic response to parathyroid hormone. Nat Commun. 2019; 10(1):1354. PMC: 6430773. DOI: 10.1038/s41467-019-08778-x. View

13.

Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H . Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell. 2002; 3(6):889-901. DOI: 10.1016/s1534-5807(02)00369-6. View

14.

Eastell R, Christiansen C, Grauer A, Kutilek S, Libanati C, McClung M . Effects of denosumab on bone turnover markers in postmenopausal osteoporosis. J Bone Miner Res. 2010; 26(3):530-7. DOI: 10.1002/jbmr.251. View

15.

Liu W, Zhou L, Zhou C, Zhang S, Jing J, Xie L . GDF11 decreases bone mass by stimulating osteoclastogenesis and inhibiting osteoblast differentiation. Nat Commun. 2016; 7:12794. PMC: 5036163. DOI: 10.1038/ncomms12794. View

16.

Chen Y, Di Grappa M, Molyneux S, McKee T, Waterhouse P, Penninger J . RANKL blockade prevents and treats aggressive osteosarcomas. Sci Transl Med. 2015; 7(317):317ra197. DOI: 10.1126/scitranslmed.aad0295. View

17.

Takayanagi H . Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol. 2007; 7(4):292-304. DOI: 10.1038/nri2062. View

18.

Rao L, Xia S, Xu W, Tian R, Yu G, Gu C . Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines. Proc Natl Acad Sci U S A. 2020; 117(44):27141-27147. PMC: 7959535. DOI: 10.1073/pnas.2014352117. View

19.

Maeda K, Kobayashi Y, Udagawa N, Uehara S, Ishihara A, Mizoguchi T . Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis. Nat Med. 2012; 18(3):405-12. DOI: 10.1038/nm.2653. View

20.

Rao S, Hu Y, Xie P, Cao J, Wang Z, Liu J . Omentin-1 prevents inflammation-induced osteoporosis by downregulating the pro-inflammatory cytokines. Bone Res. 2018; 6:9. PMC: 5876344. DOI: 10.1038/s41413-018-0012-0. View